Table 4 Multivariate analysis of factors that affect time to immunological recovery among 427 patients initiating ART at JCRC, during 2002–2006
Variables | Adjusted Hazard ratio | 95% CI | p-value |
|---|---|---|---|
Group status | |||
Non-ADC | 1.00 | ||
ADC | 1.31 | 1.03–1.28 | 0.028 |
CD4(cells/μl) | |||
>200 | 1.00 | ||
≤ 200 | 0.52 | 0.37–0.77 | 0.001 |
Viral load(copies log10/ml) | |||
< 6.0 | 1.00 | ||
≥ 6.0 | 0.91 | 0.90–1.04 | 0.806 |
Age(years) | |||
≤ 40 | 1.00 | ||
> 40 | 1.11 | 0.81–1.67 | 0.504 |
Sex | |||
Male | 1.00 | ||
Female | 1.18 | 0.85–1.67 | 0.334 |
Adherence level(%) | |||
< 95 | 1.00 | ||
≥ 95 | 2.22 | 1.57–3.15 | 0.001 |
Total lymphocyte count (cells/mm 3 ) × 10 3 | |||
<1200 | 1.00 | ||
≥ 1200 | 1.84 | 1.22–2.78 | 0.003 |